1-alpha-calcidol modulates major human monocyte antigens and toll-like receptors TLR 2 and TLR4 in vitro

European Journal of Medical Research

Volumn 10, Issue 4, 2005, Pages 179-182

  Scherberich, Juergen E ^a   Kellermeyer, M ^a   Reid, C ^a   Hartinger, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

1 alpha calcidol; Antigen modulation; CD14; Cell cultures; HLA DR; Immuno pharmacology; Monocytes; Nephropharmacology; TLR2; TLR4

Indexed keywords

ALFACALCIDOL; CD14 ANTIGEN; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CELLULAR IMMUNITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; NORMAL HUMAN; OUTCOMES RESEARCH; RANK SUM TEST; RECEPTOR DOWN REGULATION; STATISTICAL SIGNIFICANCE; TARGET CELL;

ANTICARCINOGENIC AGENTS; ANTIGENS, CD14; CELLS, CULTURED; HLA-DR ANTIGENS; HUMANS; HYDROXYCHOLECALCIFEROLS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MONOCYTES; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 17844377083     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Akira S, Takeda K, Kaisho T (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2: 675-679
2. Beutler B (2003) Science review: key inflammatory and stress pathways in critical illness- the central role of the Toll-like receptors. Crit Care 7: 39-46
3. Glorieux G, Hsu CH, de Smet R, Dhondt A et al. (1998) Inhibition of calcitriol induced monocyte CD14 expression by uremic toxins: role of purines. J Am Soc Nephrol 9: 1826-183
4. Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F et al (1998) Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 78: 23-27
5. Hanisch A, Scherberich JE (2002) Modulation of monocyte surface antigens in "fever-patients": clinical and prognostic value. Kidney Blood Press Res 25: 127
6. Kennedy MN, Mullen GE, Leifer CA, Lee C et al. (2004) A complex of soluble MD-2 and lipopolysaccharide serves as an activating tigand for Toll-like receptor 4. J Biol Chem 279: 34698-704
7. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F et al. (2002) Toll-like-receptor 4 polymorphism and atherogenesis. N Engl J Med 347: 185-192
8. Kirschning CJ, Wesche H, Ayes TM, Rothe M (1998) Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccaride. J Exp Med 188: 2091-2097
9. Moreno C, Merino J, Ramirez N, Echeverria A, Pastor F, Sanchez-Ibarrola A (2004) Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14. Microbes Infect 6: 990-995
10. Muta T, Takeshige K (2001) Essential roles of CD14 and lipopolysaccaride-binding protein for activation of toll-like receptor (TLR) 2 as well as TLR4. Eur J Biochem 268: 4580-4589
11. Nockher WA, Scherberich JE (1995) Monocyte cell-surface CD14 expression and soluble CD14 antigen in haemodialysis: Evidence for chronic exposure to LPS. Kidney Int 48:1469-1476
12. Nockher WA, Scherberich JE (1997) Expression and release of the monocyte LPS receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 158: 1345-1352
13. Nockher AW, Scherberich JE (1998) Expanded CD14+/CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 66: 2782-2790
14. Nockher WA, Wiemer J, Scherberich JE (2001) Hemodialysis monocytopenia: Differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets. Clin Exp Immunol 123: 49-55
15. Scherberich JE (2003) Proinflammatory blood monocytes: main effector and target cells in systemic and renal disease. Int J Clin Pharmacol Ther 41: 459-464
16. Scherberich JE, Nockher WA (2000) Blood monocyte phaenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure. Nephrol Dial Transplant 15: 574-578
17. Scherberich JE, Nockher WA (1999) CD14++ monocytes, CD14+CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immuno-suppressive therapy. Clin Chem Lab Med 37: 209-213
18. Scherberich JE, Estner H, Segerer W (2004) Impact of different immunosuppressive regimes on proinflammatory subsets of antigen presenting cells from renal transplant patients. Kidney & Blood Press Res 27: 177-180
19. Schuster JM, Nelson PS (2000) Toll receptors: an expanding role in our understanding of human disease. J Leuk Biol 67: 767-773
20. Shoji T, Shinohara K, Kimoto E et al (2004) Lower risk for cardiovascular mortality in oral 1-alpha-hydroxyvitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19: 179-184
21. Tokuda N, Kano M, Nomoto K, Naito S. (2000) Calcitriol therapy modulates the cellular immune response in hemodialysis patients. Am J Nephrol 20: 129-137
22. Vabulas RM, Wagner H, Schild H (2002) Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 270: 169-184
23. Wang TT, Nestel FP, Bourdeau V, Nagai Y et al (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-12
24. Weinreich T, Wüthrich RP, Booy C, Binswanger U (2001) Suppression of ICAM-1 expression in renal proximal tubular cells by 1,25-dihydroxyvitamin D3. Kidney Blood Press Res 24: 92-98
25. Zhang G, Ghosh S (2001) Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107: 13-19
26. Zhang D, Zhan G, Hayden MS, Greenblatt MB, Bussey C et al (2004) A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526